| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carbon Dioxide | 3 | 2015 | 81 | 0.660 |
Why?
|
| Animals, Laboratory | 2 | 2009 | 6 | 0.560 |
Why?
|
| Housing, Animal | 2 | 2009 | 15 | 0.560 |
Why?
|
| Ammonia | 2 | 2009 | 17 | 0.560 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2013 | 1662 | 0.410 |
Why?
|
| Intensive Care Units | 7 | 2015 | 436 | 0.390 |
Why?
|
| Histones | 5 | 2010 | 497 | 0.390 |
Why?
|
| Mammography | 2 | 2013 | 294 | 0.360 |
Why?
|
| Disposable Equipment | 2 | 2009 | 5 | 0.350 |
Why?
|
| DNA Replication | 2 | 2010 | 250 | 0.320 |
Why?
|
| Threonine | 1 | 2010 | 15 | 0.310 |
Why?
|
| Cross Infection | 3 | 2006 | 170 | 0.310 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 269 | 0.270 |
Why?
|
| Air Pollutants, Occupational | 1 | 2008 | 75 | 0.260 |
Why?
|
| Critical Illness | 4 | 2015 | 340 | 0.250 |
Why?
|
| Vancomycin Resistance | 1 | 2006 | 4 | 0.250 |
Why?
|
| Staphylococcal Infections | 2 | 2015 | 131 | 0.250 |
Why?
|
| Enterococcus | 1 | 2006 | 10 | 0.250 |
Why?
|
| Alcohols | 1 | 2006 | 13 | 0.250 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 23 | 0.250 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2006 | 29 | 0.240 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2006 | 31 | 0.240 |
Why?
|
| Hand | 1 | 2006 | 77 | 0.240 |
Why?
|
| Urography | 1 | 2006 | 13 | 0.240 |
Why?
|
| Pneumonia, Ventilator-Associated | 3 | 2015 | 42 | 0.230 |
Why?
|
| Schizophrenia | 4 | 2010 | 275 | 0.230 |
Why?
|
| Guideline Adherence | 3 | 2012 | 310 | 0.230 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 183 | 0.220 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 573 | 0.220 |
Why?
|
| Public Health Surveillance | 2 | 2015 | 27 | 0.210 |
Why?
|
| Prefrontal Cortex | 4 | 2010 | 128 | 0.200 |
Why?
|
| Animal Care Committees | 2 | 2012 | 8 | 0.190 |
Why?
|
| Animal Welfare | 2 | 2012 | 13 | 0.190 |
Why?
|
| Uterine Prolapse | 3 | 2006 | 17 | 0.170 |
Why?
|
| Female | 27 | 2016 | 34298 | 0.150 |
Why?
|
| Contrast Media | 3 | 2011 | 432 | 0.140 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2009 | 76 | 0.130 |
Why?
|
| Telemedicine | 2 | 2014 | 376 | 0.130 |
Why?
|
| Humans | 36 | 2016 | 65635 | 0.130 |
Why?
|
| Middle Aged | 18 | 2016 | 18434 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2015 | 663 | 0.130 |
Why?
|
| Hyperkalemia | 1 | 2016 | 20 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2009 | 214 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 3 | 2015 | 689 | 0.120 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2016 | 42 | 0.120 |
Why?
|
| Potassium | 1 | 2016 | 98 | 0.120 |
Why?
|
| Aged | 16 | 2016 | 15087 | 0.120 |
Why?
|
| Electroencephalography | 1 | 2016 | 156 | 0.110 |
Why?
|
| Capnography | 1 | 2015 | 7 | 0.110 |
Why?
|
| Syringes | 1 | 2015 | 12 | 0.110 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 2 | 2006 | 45 | 0.110 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2015 | 20 | 0.110 |
Why?
|
| Colorimetry | 1 | 2015 | 27 | 0.110 |
Why?
|
| Mice | 10 | 2015 | 11172 | 0.110 |
Why?
|
| Central Venous Catheters | 1 | 2015 | 17 | 0.110 |
Why?
|
| Respiratory System | 1 | 2015 | 46 | 0.110 |
Why?
|
| Animals | 15 | 2015 | 21450 | 0.110 |
Why?
|
| Gynecologic Surgical Procedures | 2 | 2006 | 49 | 0.110 |
Why?
|
| Sensitivity and Specificity | 6 | 2016 | 1172 | 0.110 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2015 | 38 | 0.110 |
Why?
|
| Catheter-Related Infections | 1 | 2015 | 42 | 0.110 |
Why?
|
| Patient Care Team | 2 | 2015 | 337 | 0.110 |
Why?
|
| Male | 23 | 2016 | 31285 | 0.110 |
Why?
|
| Radiography, Thoracic | 1 | 2015 | 117 | 0.110 |
Why?
|
| Length of Stay | 3 | 2014 | 828 | 0.110 |
Why?
|
| Muscle Development | 1 | 2015 | 62 | 0.100 |
Why?
|
| Catheterization, Central Venous | 1 | 2015 | 84 | 0.100 |
Why?
|
| Bacteremia | 1 | 2015 | 91 | 0.100 |
Why?
|
| Algorithms | 3 | 2016 | 1051 | 0.100 |
Why?
|
| Hospital Mortality | 3 | 2014 | 879 | 0.100 |
Why?
|
| Electrocardiography | 1 | 2016 | 555 | 0.100 |
Why?
|
| Critical Care | 2 | 2015 | 416 | 0.100 |
Why?
|
| Prone Position | 1 | 2013 | 28 | 0.100 |
Why?
|
| Adult | 13 | 2014 | 17508 | 0.090 |
Why?
|
| S Phase | 2 | 2010 | 79 | 0.090 |
Why?
|
| Radiodermatitis | 1 | 2012 | 11 | 0.090 |
Why?
|
| Lysine | 2 | 2010 | 93 | 0.090 |
Why?
|
| Attitude | 1 | 2012 | 102 | 0.090 |
Why?
|
| Perfusion Imaging | 1 | 2012 | 22 | 0.090 |
Why?
|
| Cystic Duct | 1 | 2011 | 5 | 0.090 |
Why?
|
| Bile Duct Diseases | 1 | 2011 | 10 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2012 | 67 | 0.090 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2012 | 22 | 0.090 |
Why?
|
| Equipment Design | 1 | 2013 | 373 | 0.090 |
Why?
|
| Oximetry | 1 | 2012 | 53 | 0.090 |
Why?
|
| Leukoaraiosis | 1 | 2012 | 45 | 0.090 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 84 | 0.090 |
Why?
|
| Alzheimer Disease | 2 | 2009 | 768 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 213 | 0.080 |
Why?
|
| Presenilin-1 | 2 | 2009 | 66 | 0.080 |
Why?
|
| Critical Pathways | 1 | 2011 | 31 | 0.080 |
Why?
|
| Data Collection | 1 | 2012 | 384 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2010 | 49 | 0.080 |
Why?
|
| Neuroimaging | 1 | 2012 | 165 | 0.080 |
Why?
|
| Nocodazole | 1 | 2010 | 14 | 0.080 |
Why?
|
| Hydroxyurea | 1 | 2010 | 19 | 0.080 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 264 | 0.080 |
Why?
|
| Camptothecin | 1 | 2010 | 29 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 708 | 0.080 |
Why?
|
| Iopamidol | 2 | 2008 | 13 | 0.080 |
Why?
|
| Acetylation | 1 | 2010 | 121 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2010 | 963 | 0.080 |
Why?
|
| CD3 Complex | 2 | 2007 | 63 | 0.080 |
Why?
|
| Quality of Health Care | 1 | 2014 | 533 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2008 | 213 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 238 | 0.070 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2007 | 37 | 0.070 |
Why?
|
| Humidity | 1 | 2009 | 13 | 0.070 |
Why?
|
| Mice, Inbred ICR | 1 | 2009 | 33 | 0.070 |
Why?
|
| Intussusception | 1 | 2008 | 16 | 0.070 |
Why?
|
| Ventilation | 1 | 2008 | 7 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 2007 | 253 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 401 | 0.070 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2007 | 6 | 0.070 |
Why?
|
| Cholesterol | 1 | 2009 | 261 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 185 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2010 | 398 | 0.070 |
Why?
|
| Smallpox Vaccine | 1 | 2007 | 11 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 345 | 0.070 |
Why?
|
| Vaccinia | 1 | 2007 | 29 | 0.070 |
Why?
|
| Temperature | 1 | 2009 | 317 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2013 | 725 | 0.060 |
Why?
|
| Vaccinia virus | 1 | 2007 | 69 | 0.060 |
Why?
|
| Ileum | 1 | 2007 | 21 | 0.060 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2007 | 87 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 404 | 0.060 |
Why?
|
| Chromatin | 3 | 2009 | 643 | 0.060 |
Why?
|
| Mutation | 3 | 2010 | 2670 | 0.060 |
Why?
|
| Nerve Endings | 1 | 2006 | 8 | 0.060 |
Why?
|
| MicroRNAs | 2 | 2010 | 714 | 0.060 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2007 | 186 | 0.060 |
Why?
|
| Calcium Channels, L-Type | 1 | 2006 | 26 | 0.060 |
Why?
|
| Esophagitis | 1 | 2006 | 9 | 0.060 |
Why?
|
| Gastritis | 1 | 2006 | 17 | 0.060 |
Why?
|
| Duodenal Diseases | 1 | 2006 | 14 | 0.060 |
Why?
|
| Lymphocytes | 1 | 2007 | 209 | 0.060 |
Why?
|
| Vagina | 1 | 2006 | 87 | 0.060 |
Why?
|
| Aged, 80 and over | 7 | 2012 | 5656 | 0.060 |
Why?
|
| Calcium | 2 | 2006 | 584 | 0.060 |
Why?
|
| Hematuria | 1 | 2006 | 23 | 0.060 |
Why?
|
| DNA, Fungal | 1 | 2005 | 58 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1042 | 0.060 |
Why?
|
| Living Donors | 1 | 2006 | 78 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2010 | 451 | 0.060 |
Why?
|
| Retrospective Studies | 5 | 2012 | 6948 | 0.060 |
Why?
|
| Receptors, Glutamate | 1 | 2005 | 18 | 0.060 |
Why?
|
| Replication Origin | 1 | 2005 | 36 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2007 | 306 | 0.060 |
Why?
|
| Sacrococcygeal Region | 1 | 2005 | 8 | 0.060 |
Why?
|
| Ligaments | 1 | 2005 | 9 | 0.060 |
Why?
|
| Metaphase | 1 | 2005 | 36 | 0.060 |
Why?
|
| Uterus | 1 | 2005 | 41 | 0.060 |
Why?
|
| Centromere | 1 | 2005 | 45 | 0.060 |
Why?
|
| Cholangitis | 1 | 2005 | 12 | 0.060 |
Why?
|
| Ureteral Obstruction | 1 | 2005 | 27 | 0.050 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2005 | 29 | 0.050 |
Why?
|
| Serine | 1 | 2005 | 90 | 0.050 |
Why?
|
| Testicular Hormones | 1 | 2004 | 11 | 0.050 |
Why?
|
| Leydig Cells | 1 | 2004 | 12 | 0.050 |
Why?
|
| Serratia Infections | 1 | 2004 | 3 | 0.050 |
Why?
|
| Serratia marcescens | 1 | 2004 | 6 | 0.050 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2004 | 11 | 0.050 |
Why?
|
| DNA Fingerprinting | 1 | 2004 | 7 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2006 | 241 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 5 | 2012 | 3500 | 0.050 |
Why?
|
| Schizosaccharomyces | 1 | 2005 | 104 | 0.050 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2004 | 15 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2005 | 97 | 0.050 |
Why?
|
| Cholestasis | 1 | 2005 | 65 | 0.050 |
Why?
|
| Tunica Intima | 1 | 2004 | 16 | 0.050 |
Why?
|
| Thrombomodulin | 1 | 2004 | 17 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2005 | 324 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 63 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2004 | 110 | 0.050 |
Why?
|
| Angioplasty, Balloon | 1 | 2004 | 55 | 0.050 |
Why?
|
| Sentinel Surveillance | 1 | 2003 | 19 | 0.050 |
Why?
|
| Equipment Contamination | 1 | 2003 | 34 | 0.050 |
Why?
|
| Immunohistochemistry | 4 | 2006 | 897 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 270 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2003 | 28 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 642 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2004 | 189 | 0.050 |
Why?
|
| Femoral Artery | 1 | 2004 | 104 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2004 | 164 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2006 | 326 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 1715 | 0.050 |
Why?
|
| Stroke | 1 | 2012 | 1220 | 0.050 |
Why?
|
| Committee Membership | 2 | 2012 | 8 | 0.050 |
Why?
|
| Infection Control | 1 | 2003 | 106 | 0.050 |
Why?
|
| Self-Assessment | 2 | 2012 | 60 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2004 | 199 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 2252 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2015 | 3328 | 0.040 |
Why?
|
| Gene Expression | 1 | 2005 | 854 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1633 | 0.040 |
Why?
|
| Academic Medical Centers | 2 | 2014 | 309 | 0.040 |
Why?
|
| Pneumonia | 1 | 2003 | 295 | 0.040 |
Why?
|
| Liver | 1 | 2005 | 874 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2012 | 2189 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2012 | 2168 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2009 | 1144 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 2015 | 318 | 0.040 |
Why?
|
| Quality of Life | 1 | 2006 | 1264 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2012 | 606 | 0.030 |
Why?
|
| Pyrroles | 2 | 2009 | 50 | 0.030 |
Why?
|
| Genotype | 2 | 2010 | 674 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2012 | 1580 | 0.030 |
Why?
|
| Immunoprecipitation | 2 | 2009 | 128 | 0.030 |
Why?
|
| Lymphocyte Count | 2 | 2007 | 71 | 0.030 |
Why?
|
| Adolescent | 4 | 2011 | 6349 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2016 | 52 | 0.030 |
Why?
|
| Cell Line | 2 | 2015 | 2029 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 1567 | 0.030 |
Why?
|
| Risk Factors | 3 | 2014 | 5466 | 0.030 |
Why?
|
| Exhalation | 1 | 2015 | 15 | 0.030 |
Why?
|
| United States | 3 | 2014 | 8166 | 0.030 |
Why?
|
| Hand Hygiene | 1 | 2015 | 10 | 0.030 |
Why?
|
| Staphylococcus | 1 | 2015 | 17 | 0.030 |
Why?
|
| Chlorhexidine | 1 | 2015 | 17 | 0.030 |
Why?
|
| Biopsy, Needle | 2 | 2006 | 133 | 0.030 |
Why?
|
| Immunoblotting | 2 | 2005 | 202 | 0.030 |
Why?
|
| Histone Deacetylase 2 | 1 | 2015 | 18 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2015 | 33 | 0.030 |
Why?
|
| MyoD Protein | 1 | 2015 | 45 | 0.030 |
Why?
|
| APACHE | 1 | 2014 | 42 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 106 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 242 | 0.030 |
Why?
|
| Machine Learning | 1 | 2016 | 195 | 0.030 |
Why?
|
| Swine | 1 | 2015 | 397 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 542 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 498 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2007 | 1588 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2015 | 201 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 1979 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 238 | 0.020 |
Why?
|
| Veterinarians | 1 | 2012 | 4 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2015 | 351 | 0.020 |
Why?
|
| Child | 3 | 2007 | 4633 | 0.020 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2012 | 5 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 200 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2012 | 104 | 0.020 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 2011 | 8 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 287 | 0.020 |
Why?
|
| Wnt Signaling Pathway | 1 | 2012 | 87 | 0.020 |
Why?
|
| Pressure Ulcer | 1 | 2011 | 36 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 348 | 0.020 |
Why?
|
| Patient Safety | 1 | 2014 | 281 | 0.020 |
Why?
|
| Diagnosis-Related Groups | 1 | 2011 | 86 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2011 | 58 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 611 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2010 | 29 | 0.020 |
Why?
|
| Cilia | 1 | 2012 | 156 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 792 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2005 | 1437 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 113 | 0.020 |
Why?
|
| Mitosis | 1 | 2012 | 222 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 1453 | 0.020 |
Why?
|
| Pain | 1 | 2012 | 400 | 0.020 |
Why?
|
| Hydroxycholesterols | 1 | 2009 | 9 | 0.020 |
Why?
|
| Heptanoic Acids | 1 | 2009 | 22 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 788 | 0.020 |
Why?
|
| Simvastatin | 1 | 2009 | 26 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 757 | 0.020 |
Why?
|
| Neuropeptide Y | 1 | 2009 | 13 | 0.020 |
Why?
|
| Parvalbumins | 1 | 2009 | 10 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1116 | 0.020 |
Why?
|
| Research Design | 1 | 2012 | 590 | 0.020 |
Why?
|
| Somatostatin | 1 | 2009 | 21 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 34 | 0.020 |
Why?
|
| Diatrizoate Meglumine | 1 | 2008 | 6 | 0.020 |
Why?
|
| Heterozygote | 1 | 2009 | 173 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2009 | 115 | 0.020 |
Why?
|
| Immunoassay | 1 | 2009 | 71 | 0.020 |
Why?
|
| Hippocampus | 1 | 2010 | 277 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2012 | 5818 | 0.020 |
Why?
|
| Time Factors | 2 | 2007 | 3777 | 0.020 |
Why?
|
| Massachusetts | 2 | 2004 | 2154 | 0.020 |
Why?
|
| Glutamate Decarboxylase | 1 | 2007 | 21 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2010 | 303 | 0.020 |
Why?
|
| ROC Curve | 1 | 2008 | 294 | 0.020 |
Why?
|
| Epitope Mapping | 1 | 2007 | 52 | 0.020 |
Why?
|
| HLA-DR1 Antigen | 1 | 2007 | 28 | 0.020 |
Why?
|
| Apolipoprotein E4 | 1 | 2007 | 46 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 301 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 1559 | 0.020 |
Why?
|
| Nifedipine | 1 | 2006 | 18 | 0.020 |
Why?
|
| Calcium Channel Agonists | 1 | 2006 | 11 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2006 | 89 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2006 | 65 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 58 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2006 | 139 | 0.010 |
Why?
|
| Parity | 1 | 2006 | 71 | 0.010 |
Why?
|
| Hypothalamus | 1 | 2006 | 135 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 170 | 0.010 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2006 | 71 | 0.010 |
Why?
|
| Stochastic Processes | 1 | 2005 | 28 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 2639 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2007 | 239 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2007 | 418 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2009 | 1026 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2007 | 270 | 0.010 |
Why?
|
| Postmortem Changes | 1 | 2005 | 12 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 491 | 0.010 |
Why?
|
| Genome, Fungal | 1 | 2005 | 42 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 992 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2007 | 322 | 0.010 |
Why?
|
| Cytogenetic Analysis | 1 | 2005 | 26 | 0.010 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2005 | 73 | 0.010 |
Why?
|
| RNA | 1 | 2009 | 427 | 0.010 |
Why?
|
| Methylation | 1 | 2005 | 130 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 2005 | 38 | 0.010 |
Why?
|
| Fetus | 1 | 2005 | 103 | 0.010 |
Why?
|
| Bufo marinus | 1 | 2004 | 47 | 0.010 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2004 | 14 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 225 | 0.010 |
Why?
|
| Gestational Age | 1 | 2005 | 194 | 0.010 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2004 | 31 | 0.010 |
Why?
|
| Sexual Maturation | 1 | 2004 | 53 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 2788 | 0.010 |
Why?
|
| Organ Size | 1 | 2004 | 174 | 0.010 |
Why?
|
| Recurrence | 1 | 2006 | 664 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 133 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 297 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 2319 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 111 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2004 | 91 | 0.010 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2004 | 68 | 0.010 |
Why?
|
| Infection Control Practitioners | 1 | 2003 | 2 | 0.010 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 1 | 2003 | 6 | 0.010 |
Why?
|
| Testosterone | 1 | 2004 | 128 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 1996 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2004 | 135 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 254 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2006 | 506 | 0.010 |
Why?
|
| Testis | 1 | 2004 | 160 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2003 | 57 | 0.010 |
Why?
|
| Nucleosomes | 1 | 2005 | 192 | 0.010 |
Why?
|
| Rabbits | 1 | 2004 | 342 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 224 | 0.010 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2004 | 104 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 377 | 0.010 |
Why?
|
| X-Ray Intensifying Screens | 1 | 2002 | 8 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 283 | 0.010 |
Why?
|
| Acute Disease | 1 | 2005 | 663 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2004 | 288 | 0.010 |
Why?
|
| Radiographic Image Enhancement | 1 | 2002 | 99 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 931 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2005 | 408 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 797 | 0.010 |
Why?
|
| Thrombosis | 1 | 2004 | 207 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 3162 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2002 | 239 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2004 | 400 | 0.010 |
Why?
|
| Infant | 1 | 2006 | 1711 | 0.010 |
Why?
|
| Logistic Models | 1 | 2004 | 1273 | 0.010 |
Why?
|
| Neurons | 1 | 2006 | 935 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2006 | 2075 | 0.010 |
Why?
|
| Age Factors | 1 | 2004 | 1592 | 0.010 |
Why?
|
| Incidence | 1 | 2004 | 1432 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 2392 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 4855 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2005 | 2113 | 0.010 |
Why?
|